Celldex Therapeutics shares owned by Birchview Capital
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Birchview Capital
from 13F filings
Historical chart of Birchview Capital investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Birchview Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $2.2M | 70k | 31.72 |